vs
Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
HEALTHY CHOICE WELLNESS CORP. is the larger business by last-quarter revenue ($18.7M vs $13.7M, roughly 1.4× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -8.9%, a 84.6% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-2.1M).
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
HCWC vs XLO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.7M | $13.7M |
| Net Profit | $-1.7M | $10.4M |
| Gross Margin | 39.1% | — |
| Operating Margin | -7.6% | -86.5% |
| Net Margin | -8.9% | 75.7% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 179.1% |
| EPS (diluted) | $-0.05 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.7M | $13.7M | ||
| Q3 25 | $19.0M | $19.1M | ||
| Q2 25 | $20.2M | $8.1M | ||
| Q1 25 | $20.3M | $2.9M | ||
| Q3 24 | $18.2M | — |
| Q4 25 | $-1.7M | $10.4M | ||
| Q3 25 | $-1.2M | $-16.3M | ||
| Q2 25 | $-339.4K | $-15.8M | ||
| Q1 25 | $-712.4K | $-13.3M | ||
| Q3 24 | $-2.7M | — |
| Q4 25 | 39.1% | — | ||
| Q3 25 | 38.8% | — | ||
| Q2 25 | 40.1% | — | ||
| Q1 25 | 38.8% | — | ||
| Q3 24 | 38.4% | — |
| Q4 25 | -7.6% | -86.5% | ||
| Q3 25 | -3.2% | -10.1% | ||
| Q2 25 | -0.2% | -177.7% | ||
| Q1 25 | -2.0% | -472.7% | ||
| Q3 24 | -2.0% | — |
| Q4 25 | -8.9% | 75.7% | ||
| Q3 25 | -6.4% | -85.4% | ||
| Q2 25 | -1.7% | -196.0% | ||
| Q1 25 | -3.5% | -452.7% | ||
| Q3 24 | -14.6% | — |
| Q4 25 | $-0.05 | $-3.74 | ||
| Q3 25 | $-0.09 | $-0.11 | ||
| Q2 25 | $-0.03 | $-0.16 | ||
| Q1 25 | $-0.07 | $-0.18 | ||
| Q3 24 | $-0.29 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $137.5M |
| Total DebtLower is stronger | $7.3M | — |
| Stockholders' EquityBook value | $7.3M | $35.3M |
| Total Assets | $33.5M | $154.7M |
| Debt / EquityLower = less leverage | 1.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $137.5M | ||
| Q3 25 | $3.0M | $103.8M | ||
| Q2 25 | $4.7M | $121.6M | ||
| Q1 25 | $1.8M | $89.1M | ||
| Q3 24 | $1.8M | — |
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $10.6M | — | ||
| Q3 24 | $11.6M | — |
| Q4 25 | $7.3M | $35.3M | ||
| Q3 25 | $5.9M | $-8.1M | ||
| Q2 25 | $5.8M | $7.1M | ||
| Q1 25 | $2.1M | $10.7M | ||
| Q3 24 | $2.9M | — |
| Q4 25 | $33.5M | $154.7M | ||
| Q3 25 | $33.7M | $133.7M | ||
| Q2 25 | $36.4M | $133.8M | ||
| Q1 25 | $34.1M | $103.7M | ||
| Q3 24 | $33.2M | — |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 5.01× | — | ||
| Q3 24 | 3.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-855.1K | $-2.0M |
| Free Cash FlowOCF − Capex | $-927.1K | $-2.1M |
| FCF MarginFCF / Revenue | -5.0% | -15.3% |
| Capex IntensityCapex / Revenue | 0.4% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $675.4K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-855.1K | $-2.0M | ||
| Q3 25 | $-308.7K | $-17.5M | ||
| Q2 25 | $1.1M | $-14.5M | ||
| Q1 25 | $1.1M | $29.0M | ||
| Q3 24 | — | — |
| Q4 25 | $-927.1K | $-2.1M | ||
| Q3 25 | $-351.3K | — | ||
| Q2 25 | $988.6K | $-14.9M | ||
| Q1 25 | $965.3K | $29.0M | ||
| Q3 24 | — | — |
| Q4 25 | -5.0% | -15.3% | ||
| Q3 25 | -1.8% | — | ||
| Q2 25 | 4.9% | -184.0% | ||
| Q1 25 | 4.8% | 988.3% | ||
| Q3 24 | — | — |
| Q4 25 | 0.4% | 0.7% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.4% | 5.0% | ||
| Q1 25 | 0.6% | 0.8% | ||
| Q3 24 | — | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCWC
| Retail Grocery | $17.1M | 91% |
| Food Service Restaurant | $1.7M | 9% |
XLO
Segment breakdown not available.
